Literature DB >> 29710299

Concerns About the Approval of Nusinersen Sodium by the US Food and Drug Administration.

Martha S Gerrity1, Vinay Prasad2,3, Adam J Obley1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29710299     DOI： 10.1001/jamainternmed.2018.0869

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  4 in total

1.  Missing Conflict of Interest Disclosure.

Authors: 
Journal:  JAMA Intern Med       Date:  2018-10-01       Impact factor: 21.873

2.  Cost-Effectiveness of Nusinersen and Universal Newborn Screening for Spinal Muscular Atrophy.

Authors:  Ali Jalali; Erin Rothwell; Jeffrey R Botkin; Rebecca A Anderson; Russell J Butterfield; Richard E Nelson
Journal:  J Pediatr       Date:  2020-07-11       Impact factor: 4.406

Review 3.  Drosophila as a Model for Assessing the Function of RNA-Binding Proteins during Neurogenesis and Neurological Disease.

Authors:  Eugenia C Olesnicky; Ethan G Wright
Journal:  J Dev Biol       Date:  2018-08-18

4.  Innovation for rare diseases and bioethical concerns: A thin thread between medical progress and suffering.

Authors:  Alberto Tommasini; Andrea Magnolato; Irene Bruno
Journal:  World J Clin Pediatr       Date:  2018-08-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.